PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Human Immune Monitoring Center, Stanford University, School of Medicine, Stanford, CA 94304, United States of America. Electronic address: kavitam@stanford.edu.\', \'Human Immune Monitoring Center, Stanford University, School of Medicine, Stanford, CA 94304, United States of America.\', \'Adamis Pharmaceuticals, San Diego, CA, 92130, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1521-6616(21)00165-010.1016/j.clim.2021.108828
?:doi
?:hasPublicationType
?:journal
  • Clinical immunology (Orlando, Fla.)
is ?:pmid of
?:pmid
?:pmid
  • 34425240
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34425240>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34425240>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all